Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
Review
. 2024 Jan 18;13(2):555.
doi: 10.3390/jcm13020555.

Prevention of Breast Cancer-Related Lymphedema: An Up-to-Date Systematic Review of Different Surgical Approaches

Domenico Pagliara  1 , Federica Grieco  2 , Silvia Rampazzo  2 , Nicola Pili  2 , Pietro Luciano Serra  2 , Roberto Cuomo  3 , Corrado Rubino  2
Affiliations
Review

Prevention of Breast Cancer-Related Lymphedema: An Up-to-Date Systematic Review of Different Surgical Approaches

Domenico Pagliara et al. J Clin Med. .

Abstract

Breast cancer-related lymphedema (BCRL) affects approximately 20% of women after breast cancer therapy. Advances in treatment have increased the life expectancy; thus, the prevalence of BCRL will continue to rise with the number of cancer survivors, hence the need to develop strategies to prevent this condition. We provide a systematic review of the literature on the primary prevention of BCRL by prophylactic lymphatic surgery (PLS). Between June and August 2022, we conducted a search of PubMed, Google Scholar and Cochrane. In the end, a total of eighteen papers were selected. The eleven studies without a control group reported only 15 of 342 patients who developed lymphedema at least six months after PLS (4.59%). The seven studies with a control group included 569 patients, 328 cases and 241 controls. Among the cases, 36 (10%) developed lymphedema. In contrast, the incidence of lymphedema in the controls was 40% (98 of 241 patients). The formulation of definite recommendations in favor of PLS is hindered by low-quality studies. There is no consensus on which technique should be preferred, nor on whether adjuvant radiotherapy might affect the efficacy of PLS. Randomized controlled trials are mandatory to conceive evidence-based recommendations.

Keywords: breast cancer-related lymphedema; lymphatic surgery; lymphedema; microsurgery; primary prevention.

PubMed Disclaimer

Conflict of interest statement

The authors declare no conflicts of interest.

Figures

Figure 1
Figure 1
PRISMA flow chart.
See this image and copyright information in PMC

Similar articles

See all similar articles

Cited by

References

    1. Maclellan R.A., Greene A.K. Lymphedema. Semin. Pediatr. Surg. 2014;23:191–197. doi: 10.1053/j.sempedsurg.2014.07.004. - DOI - PubMed
    1. Taghian N.R., Miller C.L., Jammallo L.S., O’Toole J., Skolny M.N. Lymphedema following breast cancer treatment and impact on quality of life: A review. Crit. Rev. Oncol. Hematol. 2014;92:227–234. doi: 10.1016/j.critrevonc.2014.06.004. - DOI - PubMed
    1. Jørgensen M.G., Toyserkani N.M., Sørensen J.A. The effect of prophylactic lymphovenous anastomosis and shunts for preventing cancer-related lymphedema: A systematic review and meta-analysis. Microsurgery. 2018;38:576–585. doi: 10.1002/micr.30180. - DOI - PubMed
    1. Johnson A.R., Kimball S., Epstein S., Recht A., Lin S.J., Lee B.T., James T.A., Singhal D. Lymphedema Incidence After Axillary Lymph Node Dissection: Quantifying the Impact of Radiation and the Lymphatic Microsurgical Preventive Healing Approach. Ann. Plast. Surg. 2019;82((Suppl. S4)):S234–S241. doi: 10.1097/SAP.0000000000001864. - DOI - PubMed
    1. Stuiver M.M., ten Tusscher M.R., Agasi-Idenburg C.S., Lucas C., Aaronson N.K., Bossuyt P.M. Conservative interventions for preventing clinically detectable upper-limb lymphoedema in patients who are at risk of developing lymphoedema after breast cancer therapy. Cochrane Database Syst. Rev. 2015:CD009765. doi: 10.1002/14651858.CD009765.pub2. - DOI - PMC - PubMed

LinkOut - more resources